Research Papers

25 of 234 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Promoting advanced medical services in the framework of 3PM-a proof-of-concept by the "Centro" Region of Portugal.
Regateiro FJ; Silva H; Lemos MC; Moura G; Torres P; Pereira AD; Dias L; Ferreira PL; Amaral S; Santos MAS.
EPMA J (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Artificial intelligence to improve ischemia prediction in Rubidium Positron Emission Tomography-a validation study.
Frey SM; Bakula A; Tsirkin A; Vasilchenko V; Ruff P; Oehri C; Amrein MF; Huré G; Rumora K; Schäfer I; Caobelli F; Haaf P; Mueller CE; Remppis BA; Rocca HB; Zellweger MJ.
EPMA J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Mechanical power normalized to aerated lung predicts noninvasive ventilation failure and death and contributes to the b…
Musso G; Taliano C; De Iuliis M; Paschetta E; Fonti C; Ferraris A; Druetta M; Vianou IS; Ranghino F; Riedo F; Deangelis D; Tirabassi G.
EPMA J (Unknown)
Published: 2023
2/6 Transparent
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast…
Kapinova A; Mazurakova A; Halasova E; Dankova Z; Büsselberg D; Costigliola V; Golubnitschaja O; Kubatka P.
EPMA J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Identification of potential necroinflammation-associated necroptosis-related biomarkers for delayed graft function and …
Bi Q; Wu JY; Qiu XM; Li YQ; Yan YY; Sun ZJ; Wang W.
EPMA J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine.
Lučanský V; Holubeková V; Kolková Z; Halašová E; Samec M; Golubnitschaja O.
EPMA J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Integrating oculomics with genomics reveals imaging biomarkers for preventive and personalized prediction of arterial a…
Huang Y; Li C; Shi D; Wang H; Shang X; Wang W; Zhang X; Zhang X; Hu Y; Tang S; Liu S; Luo S; Zhao K; Mordi IR; Doney ASF; Yang X; Yu H; Li X; He M.
EPMA J (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
New insight of metabolomics in ocular diseases in the context of 3P medicine.
Zhang Q; Wang N; Rui Y; Xia Y; Xiong S; Xia X.
EPMA J (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multi-omics and immune cells' profiling of COVID-19 patients for ICU admission prediction: in silico analysis and an in…
Zhu K; Chen Z; Xiao Y; Lai D; Wang X; Fang X; Shu Q.
EPMA J (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Diagnostic accuracy of autoverification and guidance system for COVID-19 RT-PCR results.
Cai Y; Liu M; Wu Z; Tian C; Qiu S; Li Z; Xu F; Li W; Zheng Y; Xu A; Xie L; Tan X.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Body mass index-based predictions and personalized clinical strategies for colorectal cancer in the context of PPPM.
Gu YJ; Chen LM; Gu ME; Xu HX; Li J; Wu LY.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Mutual effect of homocysteine and uric acid on arterial stiffness and cardiovascular risk in the context of predictive,…
Wu Z; Zhang H; Li Z; Li H; Miao X; Pan H; Wang J; Liu X; Kang X; Li X; Tao L; Guo X.
EPMA J (Unknown)
Published: 2022
4/6 Transparent
Code Funding Declared
Radiomics based on readout-segmented echo-planar imaging (RS-EPI) diffusion-weighted imaging (DWI) for prognostic risk …
Liu Z; Wang Y; Shen F; Zhang Z; Gong J; Fu C; Shen C; Li R; Jing G; Cai S; Zhang Z; Sun Y; Tong T.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Sleep apnea predicts cardiovascular death in patients with Marfan syndrome: a cohort study.
Gessler N; Wohlmuth P; Anwar O; Debus ES; Eickholt C; Gunawardene MA; Hakmi S; Heitmann K; Rybczynski M; Schueler H; Sheikhzadeh S; Tigges E; Wiest GH; Willems S; Adam E; von Kodolitsch Y.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Hair cortisol level might be indicative for a 3PM approach towards suicide risk assessment in depression: comparative a…
Karabatsiakis A; de Punder K; Salinas-Manrique J; Todt M; Dietrich DE.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, a…
Kubatka P; Mazurakova A; Koklesova L; Samec M; Sokol J; Samuel SM; Kudela E; Biringer K; Bugos O; Pec M; Link B; Adamkov M; Smejkal K; Büsselberg D; Golubnitschaja O.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comp…
Mazurakova A; Samec M; Koklesova L; Biringer K; Kudela E; Al-Ishaq RK; Pec M; Giordano FA; Büsselberg D; Kubatka P; Golubnitschaja O.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Implementing a preimplantation proteomic approach to advance assisted reproduction technologies in the framework of pre…
Kanaka V; Proikakis S; Drakakis P; Loutradis D; Tsangaris GT.
EPMA J (Unknown)
Published: 2022
2/6 Transparent
Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine app…
Harms RL; Ferrari A; Meier IB; Martinkova J; Santus E; Marino N; Cirillo D; Mellino S; Catuara Solarz S; Tarnanas I; Szoeke C; Hort J; Valencia A; Ferretti MT; Seixas A; Santuccione Chadha A.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?
Hamdy NM; Shaker FH; Zhan X; Basalious EB.
EPMA J (Unknown)
Published: 2022
2/6 Transparent
Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and p…
Koklesova L; Mazurakova A; Samec M; Kudela E; Biringer K; Kubatka P; Golubnitschaja O.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Evaluation of thermal sensitivity is of potential clinical utility for the predictive, preventive, and personalized app…
Mun S; Park K; Lee S.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients.
Brunmair J; Bileck A; Schmidl D; Hagn G; Meier-Menches SM; Hommer N; Schlatter A; Gerner C; Garhöfer G.
EPMA J (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants f…
Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL.
EPMA J (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression-3PM pathw…
Kubatka P; Mazurakova A; Samec M; Koklesova L; Zhai K; Al-Ishaq R; Kajo K; Biringer K; Vybohova D; Brockmueller A; Pec M; Shakibaei M; Giordano FA; Büsselberg D; Golubnitschaja O.
EPMA J (Unknown)
Published: 2021
2/6 Transparent
Funding Declared